On June 26, 2025, the Division of Justice (“DOJ”) introduced {that a} Distant Affected person Monitoring (“RPM”) supplier (“Firm”) and its doctor proprietor, paid $1.29 million to settle allegations of submitting false claims to Medicare beneath the False Claims Act (“FCA”). This settlement highlights the elevated development in RPM companies, whereas noting the federal government’s scrutiny of such companies.
RPM entails utilizing digital units to remotely monitor a affected person’s well being past the capabilities of a standard scientific setting. These units transmit affected person well being info to suppliers with out requiring an in-office presence. RPM is mostly used with blood strain, weight and glucose stage displays, as they’re extensively used units for power illness administration, greatest supported by constant knowledge factors to drive care planning. Whereas RPM is a reimbursable service for conventional Medicare fee-for-service enrollees, the federal government requires the next parts:
- The enrollee should have a power or acute situation.
- RPM should be carried out with an internet-connected gadget accredited by the Meals and Drug Administration (“FDA”).
- RPM should accumulate and transmit a minimal quantity of information inside 30 days.
DOJ Allegations
Underneath the “reverse false claims” provision of the FCA, the Firm did not refund the federal authorities for two.5 years of claims for improperly supplied RPM companies. Particularly, the DOJ alleged the next:
- Kickbacks: The Firm allegedly paid doctor follow teams unlawful kickbacks in change for referrals. The Firm and its billing affiliate supplied doctor practices with complimentary entry to EHR techniques. In flip, the Firm reviewed affected person information to find out RPM eligibility after which cold-called sufferers to generate referrals.
- Improper Billing: The Firm billed Medicare for RPM companies that the DOJ discovered to be non-reimbursable, together with:
- The Firm didn’t present sufferers with FDA-approved units for the requisite two-year interval. As a substitute, sufferers manually uploaded knowledge through a cellular app, which, in keeping with the FDA, isn’t a medical gadget. In some cases, the Firm collected affected person knowledge by calling sufferers when the sufferers didn’t use the app.
- Even in cases when units had been supplied, the Firm didn’t correctly invoice for its companies as a result of it didn’t accumulate sufficient days’ value of information (16 days/month). As a substitute, the Firm checked their app for engagement in the future per 30 days.
- Lastly, it was additional alleged that the Firm intercepted affected person messages meant for his or her doctor and relied on untrained workers to find out if escalation was needed.
Sensible Takeaways
RPM is well-positioned to play a transformational position in power illness administration, particularly as AI integration continues, wearable gadget adoption accelerates and federal well being priorities shift in the direction of power illness prevention. Nonetheless, because the use and reimbursement of RPM proceed to develop, so too will federal scrutiny. RPM suppliers ought to proactively assess their applications to mitigate reimbursement dangers and guarantee regulatory alignment to stop false claims threat.
Suppliers counting on RPM should guarantee their utilization meets CMS reimbursement necessities, together with utilizing FDA-approved units with correct knowledge assortment protocols.
When you have any questions or would love extra info, please contact:
Particular because of Summer time Affiliate Nick Baker for his help within the preparation of this text.
Corridor Render weblog posts and articles are meant for informational functions solely. For moral causes, Corridor Render attorneys can not—outdoors of an attorney-client relationship—reply particular questions that may be authorized recommendation.